Back

The second phase-3 multi-center trial of flurpiridaz F-18 PET myocardial perfusion imaging for coronary artery disease evaluation

27 August 2023 (15:30 - 15:39)
Organised by: Logo
Congress Presentation Part of: Molecular imaging of the heart: the added value of PET Positron Emission Tomography (PET) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Jeroen Bax

Leiden University Medical Center, Leiden (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Assessment of left atrial fibrosis by 18F-FDG PET/CT in persistent atrial fibrillation : comparison to electroanatomical mapping and cMR late gadolinium enhancement.
Mr T. Raoult (Orleans, FR)
Abstract Slides Video
Presentation thumbnail
Left atrial glucose metabolism by 18F-FDG PET/CT in persistent atrial fibrillation and after return to sinus rhythm
Doctor S. Marchandise (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Increased aortic valve uptake of sodium fluoride is associated with higher cardiovascular risk: assessing pathophysiology with PET/CT
Doctor J. Borges-Rosa (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Myocardial fibrosis activity following ST-segment elevation myocardial infarction
Doctor A. Barton (Edinburgh, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular imaging of the heart: the added value of PET
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 15:30 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Trials: coronary artery disease and interventions
thumbnail
Congress Presentation
Myocardial perfusion positron emission tomography: flurpiridaz
thumbnail
Congress Session
Molecular imaging of the heart: the added value of PET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources